Mednet Logo

What is your treatment approach for hidradenitis suppurativa?

Do you reserve biologics for more systemic involvement? When do you initiate biologics such as secukinumab?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Dermatology · Wayne State University
Answered on

In HS, we talk about a "window of opportunity." It's the idea that since HS causes tissue damage, scarring, and tunneling, treatment becomes more difficult as the disease progresses. A delay of 10 years between symptom onset and starting adalimumab was associated with a 1.92x higher odds that the pa...

Join for free or sign in to see the full answer